Post-earnings recap
Reported
Thu, May 7, 2026
EPS actual
$-0.15
EPS est.
$-0.11
EPS surprise
-36.36%
1-day move
-0.40%
—
Est. EPS
$0.97
Est. Rev
$754M
Impl. Move
±9.1%
Cytek Biosciences reported a loss of $0.15 per share, which was below expectations. The stock reacted slightly down by 0.4%, indicating that investors may have been disappointed by the earnings miss. Without additional context from management commentary or guidance, it remains unclear how the company plans to address these results moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.15 | N/A | -36.36% |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.